Post

Novocure’s TTFields device slows metastasis in NSCLC

Novocure’s Tumor Treating Fields (TTFields) therapy met its primary endpoint in the Phase III METIS trial by slowing the progression …

Nexalin’s device improves symptoms of mild traumatic brain injury

Nexalin Technology has revealed positive data from a clinical trial that evaluated its neurostimulation device in veteran patients with combat-related …

Photopharmics kickstarts phototherapy trial for Parkinson’s disease 

US-based equipment manufacturer Photopharmics has announced the initiation of its ‘Celeste light for PD’ clinical trial investigating the Celeste phototherapy …

Seyltx buys Algernon’s Phase II chronic cough therapy

US-based Seyltx has closed an agreement to acquire Algernon Pharmaceuticals’ chronic cough therapy, ifenprodil (NP-120). Algernon received a purchase price …

Iambic begins dosing in trial of IAM1363 for HER2-driven cancer

Iambic Therapeutics has initiated the dosing of the first subject in its Phase I/Ib clinical trial of IAM1363, a novel …